Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Cyclo Therapeutics, Inc.Financial_Report.xls
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULE 13(A)-14(A) (UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002). - Cyclo Therapeutics, Inc.f10q0912ex31i_ctdholdings.htm
10-Q - QUARTERLY REPORT - Cyclo Therapeutics, Inc.f10q0912_ctdholdings.htm
EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Form 10-Q of CTD Holdings, Inc. (the “Company”) for the fiscal quarter ended September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, C.E. Rick Strattan, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date:  November 13, 2012
 
/s/ C.E. Rick Strattan
   
C.E. Rick Strattan
   
Chief Executive Officer
   
(principal executive, financial and accounting officer)